Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

NKG2D; CAR T; IL-7; prostate cancer; cell therapy; CD19-CAR-T; B cell aplasia; KIR; PD-1; inhibitory CAR; tumor-infiltrating lymphocytes; tumor microenvironment; immunotherapy; NK cells; cancer stem cells (CSCs); antibody-dependent cellular cytotoxicity (ADCC); differentiation; cytotoxicity; IFN-γ; osteoclasts; MICA/B mAb; DNA methylation; RNA methylation; S-adenosylmethionine (SAM); cancer; innate immunity; adaptive immunity; T cells; m6A; PD-L1; resistance; immune checkpoints; cancer vaccine; combination immunotherapy; TCR diversity; organ transplantation; carcinoma; epidemiologic studies; immunosuppression; CTLA-4; Treg cells; immune checkpoint inhibitors; CD28; antigen-presenting cells; IL15; colon cancer; melanoma; uveal; BAP1; anti-PD-1; anti-CTLA-4; TIL; classical and endemic Kaposi Sarcoma; systemic treatment; multi-state modelling; treatment free interval; chemotherapy; interferon; triple negative breast cancer; immunomodulation; bispecific antibody; sortase A; chemo-enzymatic approach; anti-CD20 antibody; Fab; BiFab; colorectal cancer; dendritic cells; Atypical Chemokine Receptor 4 (ACKR4); T-cell priming; immune checkpoint blockade; primary liver cancer; kynurenine pathway; immune evasion; indoleamine 2,3 dioxygenase 1; tryptophan 2,3 dioxygenase 2; IDO inhibitor; antigen presenting cells; n/a